A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

A*STAR researchers uncover how bacteria and the immune system generate alarm behavior in fish.

A*STAR researchers have turned a bacterial protein into a biosensor that can be used to visualize interactions between proteins.

A*STAR scientists have found a way to boost the activity of neutrophils, a subset of immune cells, against disease-causing fungi.

From replacing the insulin producing cells of the body, to serving as genetic and drug screening platforms, stem cells could change the landscape of available treatments for diabetes.

Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.

Estimation plots provide researchers with a more complete picture of the significance of their results than traditional P values, say A*STAR scientists.

By interfering with the production and downstream activity of a molecule called Agrin in tumors, scientists can stop the sprouting of blood vessels that promote cancer progression.

Researchers at A*STAR have invented a biodegradable thermogel that mimics the clear, gelatinous substance called vitreous in the eye.

Mutations in the gene HNF4A impair liver and pancreas development, indicating that maturity-onset diabetes of the young starts much earlier than initially thought.

An automated machine learning system for analyzing leg movements in fruit flies is helping A*STAR researchers shed light on how neurodegenerative diseases develop.

In times of stress, cancer cells move a protein normally found inside the cell to the cell surface, making it accessible to antibodies for immunotherapy.

Disruption of the methionine cycle in tumor-initiating cells disarms their tumorigenic capabilities, researchers say.